Construction and analysis of a detailed three-dimensional model of the ligand binding domain of the human B cell receptor CD40

Proteins: Structure, Function and Genetics

Volumn 27, Issue 1, 1997, Pages 59-70

  Bajorath, Jürgen ^a   Aruffo, Alejandro ^b  

^a BRISTOL MYERS SQUIBB   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

Author keywords

CD40 receptor ligand interactions; comparative protein modeling; model quality; sequence similarity; sequence structure compatibility

Indexed keywords

CD40 ANTIGEN; LYMPHOCYTE RECEPTOR;

ANTIBODY COMBINING SITE; ANTIGEN BINDING; ARTICLE; B LYMPHOCYTE; LYMPHOCYTE PROLIFERATION; MOLECULAR DYNAMICS; MOLECULAR INTERACTION; MOLECULAR MODEL; PRIORITY JOURNAL; RECEPTOR BINDING; STRUCTURE ANALYSIS;

AMINO ACID SEQUENCE; ANIMALS; ANTIGENS, CD40; B-LYMPHOCYTES; CARRIER PROTEINS; HUMANS; LIGANDS; MICE; MODELS, MOLECULAR; MOLECULAR SEQUENCE DATA; PROTEIN FOLDING; RECEPTORS, TUMOR NECROSIS FACTOR; SEQUENCE HOMOLOGY, AMINO ACID; STEREOISOMERISM; TNF RECEPTOR-ASSOCIATED FACTOR 3; TUMOR NECROSIS FACTOR RECEPTOR-ASSOCIATED PEPTIDES AND PROTEINS;

EID: 0031036294     PISSN: 08873585     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0134(199701)27:1<59::AID-PROT7>3.0.CO;2-I     Document Type: Article

References (45)

1. Noelle, R.J., Ledbetter, J.A., Aruffo, A. CD40 and its ligand are an essential ligand-receptor pair for thymus-dependent B cell activation. Immunol. Today 13:431-433, 1992.
2. Hollenbaugh, D., Ochs, H.D., Noelle, R.J., Ledbetter, J.A., Aruffo, A. 1994. The role of CD40 and its ligand in the regulation of the immune response. In: "Immunological Reviews". Möller, G., (ed.). Copenhagen: International Publishers, 1994:1-37.
3. Armitage, R.J., Fanslow, W.C., Strockbine, L., Sato, T.A., Clifford, K.N., Macduff, B.M., Anderson, D.M., Gimpel, S.D., Davis-Smith, T., Maliszewski, C.R., Clark, E.A., Smith, C.A., Grabstein, K.H., Cosman, D., Spriggs, M.K. Molecular and biological characterization of a murine ligand for CD40. Nature 357:80-82, 1992.
4. Hollenbaugh, D., Grosmaire, L.S., Kullas, C.D., Chalupny, N.J., Braesch-Andersen, S., Noelle, R.J., Stamenkovic, I., Ledbetter, J.A., Aruffo, A. The human T cell antigen gp39, a member of the TNF gene family, is a ligand for the CD40 receptor: Expression of a soluble form of gp39 with B cell co-stimulatory activity. EMBO J. 11:4313-4321, 1992.
5. Spriggs, M.K., Armitage, R.J., Strockbine, L., Clifford, K.N., Macduff, B.M., Sato, T.A., Maliszewski, C.R., Fanslow, W.C. Recombinant human CD40 ligand stimulates B cell proliferation and immunoglobulin E secretion. J. Exp. Med. 176:1543-1550, 1992.
6. Graf, D., Korthauer, U., Mages, H.W., Senger, G., Kroczek, R.A. Cloning of TRAP, a ligand for CD40 on human B cells. Eur. J. Immunol. 22:3191-3194, 1992.
7. Lane, P., Traunecker, A., Hubele, S., Inui, S., Lanzaveccia, A., Gray, D. Activated human T cells express a ligand for the human B cell-associated antigen CD40 which participates in T cell-dependent activation of B lymphocytes. Eur. J. Immunol. 22:2573-2578, 1992.
8. Hermann, P., Blanchard, D., de Saint-Vis, B., Fossiez, F., Gaillard, C., Vanbervliet, B., Briere, F., Banchereau, J., Galizzi, J.-P. Expression of a 32-kDa ligand for the CD40 antigen on activated human T lymphocytes. Eur. J. Immunol. 23:961-964, 1993.
9. Lederman, S., Yellin, M.J., Cleary, A.M., Pernis, A., Inghirami, G., Cohn, L.E., Covey, L.R., Lee, J.J., Rothman, P., Chess, L. T-BAM/CD40-L on helper T lymphocytes augments lymphokine-induced B cell Ig isotype switch recombination and rescues B cells from programmed cell death. J. Immunol. 152:2163-2171, 1994.
10. Noelle, R.J., Roy, M., Shepherd, D.M., Stamenkovic, I., Ledbetter, J.A., Aruffo, A. A 39 kDa protein on activated helper T cells binds CD40 and transduces the signal for cognate activation of B cells. Proc. Natl. Acad. Sci. USA 89:6550-6554, 1992.
11. Farrah, T., Smith, C.A. Emerging cytokine family. Nature 358:26, 1992.
12. Bajorath, J., Stenkamp, R., Aruffo, A. Knowledge-based model building of proteins: Concepts and examples. Protein Sci. 2:317-334, 1993.
13. Beutler, B., van Huffel, C. Unraveling function in the TNF ligand and receptor families. Science 264:667-668, 1994.
14. Smith, C.A., Farrah, T., Goodwin, R.G. The TNF receptor superfamily of cellular and viral proteins: Activation, costimulation, and death. Cell 76:959-962, 1994.
15. Peitsch, M.C., Jongeneel, C.V. A 3-D model for the CD40 ligand predicts that it is a compact trimer similar to tumor necrosis factor. Int. Immunol. 5:233-238, 1993.
16. Bajorath, J., Marken, J.S., Chalupny, N.J., Spoon, T.L., Siadak, A.W., Gordon, M., Noelle, R.J., Hollenbaugh, D., Aruffo, A. Analysis of gp39/CD40 interactions using molecular models and site directed mutagenesis. Biochemistry 34:9884-9892, 1995.
17. Jones, E.Y., Stuart, D.I., Walker, N.P.C. Structure of tumor necrosis factor. Nature 338:225-228, 1989.
18. Eck, M.J., Sprang, S.R. The structure of tumor necrosis factor at 2.6 Å resolution: Implications for receptor binding. J. Biol. Chem. 264:17595-17606, 1989.
19. Eck, M.J., Ultsch, M., Rinderknecht, E., de Vos, A.M., Sprang, S.R. The structure of human lymphotoxin (tumor necrosis factor-β) at 1.9 Å resolution. J. Biol. Chem. 267: 2119-2122, 1992.
20. Banner, D.W., D'Arcy, A., Janes, W., Gentz, R., Schoenfeld, H.-J., Broger, C., Loetscher, H., Lesslauer, W. Crystal structure of the soluble human 55 kd TNF receptor-human TNFβ complex: Implications for TNF receptor activation. Cell 73:431-445, 1993.
21. Bajorath, J., Chalupny, N.J., Marken, J.S., Siadak, A.W., Skonier, J., Gordon, M., Hollenbaugh, D., Noelle, R.J., Ochs, H.D., Aruffo, A. Identification of residues on CD40 and its ligand which are critical for receptor-ligand interactions. Biochemistry 34:1833-1844, 1995.
22. Bajorath, J., Seyama, K., Nonoyama, S., Ochs, H.D., Aruffo, A. Classification of mutations in the human CD40 ligand, gp39, that are associated with X-linked hyper IgM syndrome. Protein Science 5:531-534, 1996.
23. Karpusas, M., Hsu, Y.-M., Wang, J.-H., Thompson, J., Lederman, S., Chess, L., Thomas, D. 2 Å crystal structure of an extracellular fragment of human CD40 ligand. Structure 3:1031-1039, 1995.
24. Aruffo, A., Farrington, M., Hollenbaugh, D., Li, X., Milatovich, A., Nonoyama, S., Bajorath, J., Grosmaire, L.S., Stenkamp, R., Neubauer, M., Roberts, R.L., Noelle, R.J., Ledbetter, J.A., Francke, U., Ochs, H.D. The CD40 ligand, gp39, is defective in activated T cells from patients with X-linked hyper IgM syndrome. Cell 72: 291-300, 1993.
25. Allen, R.C., Armitage, R.J., Conley, M.E., Rosenblatt, H., Jenkins, N.A., Copeland, N.G., Bedell, M.A., Edelhoff, S., Disteche, C.M., Simoneaux, D.K., Fanslow, W.C., Belmont, J., Spriggs, M.K. 1993. CD40 ligand gene defects responsible for X-linked hyper IgM syndrome. Science 259: 990-993, 1993.
26. Durandy, A., Schiff, C., Bonnefoy, J.Y., Forveille, M., Rousset, F., Mazzei, G., Milili, M., Fischer, A. Induction by anti-CD40 antibody or soluble CD40 ligand and cytokines of IgG, IgA and IgE production by B cells from patients with X-linked hyper IgM syndrome. Eur. J. Immunol. 23: 2294-2299, 1993.
27. Korthauer, U., Graf, D., Mages, H.W., Briere, F., Padayachee, M., Malcolm, S., Ugazio, A.G., Notarangelo, L.D., Levinsky, R.J., Kroczek, R.A. Defective expression of T-cell CD40 ligand causes X-linked immunodeficiency with hyper-IgM. Nature 361:539-541, 1993.
28. Di Santo, J.P., Bonnefoy, J.Y., Gauchat, J.F., Fischer, A., de Saint-Basile, G. CD40 ligand mutations in X-linked immunodeficiency with hyper-IgM. Nature 361:541-543, 1993.
29. Fuleihan, R., Ramesh, N., Loh, R., Jabara, H., Rosen, R.S., Chatila, T., Fu, S.M., Stamenkovic, I., Geha, R.S. Defective expression of the CD40 ligand in X chromosome-linked immunoglobulin deficiency with normal or elevated IgM. Proc. Natl. Acad. Sci. USA 90:2170-2173, 1993.
30. Ramesh, N., Fuleihan, R., Ramesh, V., Lederman, S., Yellin, M.J., Sharma, S., Chess, L., Rosen, F.S., Geha, R.S. Deletions in the ligand for CD40 in X-linked immunoglobulin deficiency with normal or elevated IgM (HIGMX-1). Int. Immunol. 5:769-773, 1993.
31. Villa, A., Notarangelo, L.D., Di Santo, J.P., Macchi, P.P., Strina, D., Frattini, A., Lucchini, F., Patrosso, C.M., Giliani, S., Mantuano, E., Agosti, S., Nocera, G., Kroczek, R.A., Fischer, A., Ugazio, A.G., De Saint Basile, G., Vezzoni, P. Organization of the human CD40L gene: Implications for molecular defects in X chromosome-linked hyper IgM syndrome and prenatal diagnosis. Proc. Natl. Acad. Sci. USA 91:2110-2114, 1994.
32. Saiki, O., Tanaka, T., Wada, Y., Uda, H., Inoue, A., Katada, Y., Izeki, M., Iwata, M., Nunoi, H., Matsuda, I., Kinoshita, N., Kishimoto, T. Signaling through CD40 rescues IgE but not IgG or IgA secretion in X-linked immunodeficiency with hyper-IgM. J. Clin. Invest. 95: 510-514, 1995.
33. Macchi, P., Villa, A., Strina, D., Sacco, M.G., Morali, F., Brugnoni, D., Giliani, S., Mantuano, E., Fasth, A., Andersson, B., Zegers, B.J.M., Cavagni, G., Reznick, I., Levy, J., Zan-Bar, I., Porat, Y., Airo, P., Plebani, A., Vezzoni, P., Notarangelo, L.D. Characterization of nine novel mutations in the CD40 ligand gene in patients with X-linked hyper IgM syndrome of various ancestry. Am. J. Hum. Genet. 56:898-906, 1995.
34. Naismith, J.H., Devine, T.Q., Brandhuber, B.J., Sprang, S.R. Crystallographic evidence for dimerization of unliganded tumor necrosis factor receptor. J. Biol. Chem. 270: 13303-13307, 1995.
35. Seibel, G., Singh, U.C., Weiner, P.K., Caldwell, J., Kollman, P. AMBER 3.0 revision A. San Francisco. University of California at San Francisco, 1990.
36. Ponder, J.W., Richards, F.M. Tertiary templates for proteins. Use of packing criteria in the enumeration of allowed sequences for different structural classes. J. Mol. Biol. 193:775-791, 1987.
37. Bajorath, J., Fine, R.M. On the use of minimization from many randomly generated loop structures in modeling antibody combining sites. Immunomethods 1:137-146, 1992.
38. Bruccoleri, R.E., Novotny, J. Antibody modeling using the conformational search program CONGEN. Immunomethods 1:96-106, 1992.
39. Laskowski, R.A., MacArthur, M.W., Moss, D.S., Thornton, J.M. PROCHECK: A program to check the stereochemical quality of protein structures. J. Appl. Crystallogr. 26:283-291, 1993.
40. Sippl, M.J. Recognition of errors in three-dimensional structures of proteins. Proteins 17:355-362, 1993.
41. Richardson, J.S. Schematic drawings of protein structures. Methods Enzymol. 115:359-380, 1985.
42. Bruccoleri, R.E., Haber, E., Novotny, J. Structure of antibody hypervariable region loops reproduced by a conformational search algorithm. Nature 335:564-568, 1988.
43. Chothia, C., Lesk, A.M. The relation between the divergence of sequence and structure in proteins. EMBO J. 5:823-826, 1986.
44. Mosimann, S., Meleshko, R., James, M.N.G. A critical assessment of comparative molecular modeling of tertiary structures of proteins. Proteins 23, 301-317, 1995.
45. Novotny, J., Bruccoleri, R.E., Karplus, M. An analysis of incorrectly folded protein models. Implications for structure prediction. J. Mol. 177:787-818, 1984.